Medical News Today -- The largest randomised study to investigate the treatment and prevention of recurrent venous thromboembolism (VTE) has recruited the first of its 7500 patients, researchers announced last week during the 54th Congress for Thrombosis and Haemostasis (Nuremberg, Germany).
